A carregar...
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
Malignant mesothelioma (MMe) is a cancer with poor prognosis and resistance to standard treatments. Recent reports have highlighted the role of the BRCA1 associated protein 1 gene (BAP1) in the development of MMe. In this study, the chemosensitivity of human mesothelioma cell lines carrying BAP1 wil...
Na minha lista:
Publicado no: | Int J Mol Sci |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI
2019
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359027/ https://ncbi.nlm.nih.gov/pubmed/30669483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20020429 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|